Arch Public
NVDAStocksCash yieldShort term

Scalp Price Imbalances on NVDA

Strategy #51 · NVDA 1h · Market Wave · 1 Hour chart

Backtested As of 7 Aug 2026 · 22 Jul 2025 – 22 Jul 2026 · $100,000 starting capital

Strategy return

+74.9%

Buy and hold NVDA

+26.3%

Test length

1 year

CAGR not shown under a year

The chart

Every trade from the backtest, straight from TradingView.

Blue arrows: buys, with order sizeMagenta marks: sells1 Hour bars
TradingView backtest chart of strategy #51 on NVDA, 1 Hour, with every buy and sell marked

Against its benchmarks

NVDA 1h+74.9%
Buy and hold NVDA+26.3%

Total return over the test period, backtested.

Past and backtested performance does not guarantee future results.

Results at your account size

$

Net profit

+$74,895

Ending value

$174,895

Cash profit

+$69,005

Asset accumulated

833 NVDA

We'll email this strategy's results at $100,000.

How it trades

Algorithm
Market Wave
Chart
1 Hour
Horizon
Short term
Aim
Cash yield: aims for profit taken in cash
Test period
22 Jul 2025 – 22 Jul 2026
Starting capital
$100,000
Fees and slippage
Not stated
Data source
TradingView backtest

Exact settings come with every client account, the free tier included, in Strategy Lab Pro.

Start free
TradingView backtest chart of strategy #50 on NVDA, 1 Day, with every buy and sell marked
NVDAStocksCash yield

Cash Yield from a rising NVDA

Strategy #50 · Market Wave · 1 Day chart

Strategy+102.8%
Buy and hold NVDA+82.8%

Backtested · 1 Jun 2024 – 1 Jun 2026

TradingView backtest chart of strategy #77 on MRNA, 4 Hours, with every buy and sell marked
MRNAStocksCash yield

Trading the MRNA Pop

Strategy #77 · Market Wave · 4 Hours chart

Strategy+531.4%
Buy and hold MRNA+399.4%

Backtested · 1 Jan 2026 – 25 Aug 2026

Start free